PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2010 | 68 |
| 2011 | 50 |
| 2012 | 72 |
| 2013 | 66 |
| 2014 | 56 |
| 2015 | 75 |
| 2016 | 78 |
| 2017 | 42 |
| 2018 | 54 |
| 2019 | 65 |
| 2020 | 43 |
| 2021 | 51 |
| 2022 | 60 |
| 2023 | 46 |
| 2024 | 70 |
| 2025 | 79 |
| 2026 | 38 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Nucl Med Mol Imaging"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Current Status of PSMA-Targeted Agents Based on Small Molecules for Prostate Cancer in Preclinical Studies.
- Muzammal A, Lee KC, Eom S.
- Nucl Med Mol Imaging. 2026 Jan 26;60(3):204-220. doi: 10.1007/s13139-025-00979-1.
- PMCID: PMC13247089
Muzammal A, et al.Nucl Med Mol Imaging. 2026.PMCID: PMC13247089 -
Automated Synthesis of Radiopharmaceuticals: Technology, Applications, and Regulatory Perspectives.
- Ko N, Lee SJ, Oh SJ.
- Nucl Med Mol Imaging. 2025 Oct 16;60(3):157-165. doi: 10.1007/s13139-025-00956-8.
- PMCID: PMC13246981
Ko N, et al.Nucl Med Mol Imaging. 2025.PMCID: PMC13246981 -
Development of Antibody and Antibody Fragment-Based Radiopharmaceuticals for Cancer Imaging and Therapy.
- Kang CS.
- Nucl Med Mol Imaging. 2025 Dec 2;60(3):166-184. doi: 10.1007/s13139-025-00969-3.
- PMCID: PMC13246997
Kang CS.Nucl Med Mol Imaging. 2025.PMCID: PMC13246997 -
Enhanced Lymphoma Subtype Classification and Prognosis Using Machine Learning with 18F-FDG PET/CT Radiomics: Beyond SUVmax.
- Hasanabadi S, Aghamiri SMR, Abin AA, Vosoughi H, Emami F, Bakhshayesh Karam M, Nejabat M, Dorudinia A, Arabi H, Zaidi H.
- Nucl Med Mol Imaging. 2026 Apr 27;60(5):566-580. doi: 10.1007/s13139-026-01017-4.
- PMCID: PMC13627636
Hasanabadi S, et al.Nucl Med Mol Imaging. 2026.PMCID: PMC13627636 -
Site-Specific Patterns of Distant Relapse on ^18F-FDG PET/Contrast-Enhanced CT According to Molecular Subtype in Breast Cancer: A Retrospective Cohort Study.
- Chiaravalloti A, Vanni G, Verdesca L, Di Biagio D, Tavolozza M, Buonomo OC, Schillaci O.
- Nucl Med Mol Imaging. 2026 May 7;60(5):590-599. doi: 10.1007/s13139-026-01022-7.
- PMCID: PMC13627589
Chiaravalloti A, et al.Nucl Med Mol Imaging. 2026.PMCID: PMC13627589 -
Everolimus Related Acute Steatohepatitis Detected on 68Ga-Dotatate PET/CT in a Patient with Metastatic Duodenal Neuroendocrine Tumor.
- Wiltshire J, Parihar AS.
- Nucl Med Mol Imaging. 2026 Feb 27;60(5):648-649. doi: 10.1007/s13139-026-00993-x.
- PMCID: PMC13627580
Wiltshire J, et al.Nucl Med Mol Imaging. 2026.PMCID: PMC13627580 -
From Patient Selection to Surveillance: Artificial Intelligence Applications in Radioiodine Therapy - A Systematic Review.
- Obrycka M, Abdelrazek S, Żukowski Ł, Myśliwiec J, Szumowski P.
- Nucl Med Mol Imaging. 2026 Jul 11;60(5):490-515. doi: 10.1007/s13139-026-01049-w.
- PMCID: PMC13627506
Obrycka M, et al.Nucl Med Mol Imaging. 2026.PMCID: PMC13627506 -
Current Status of Theranostics in West Asia: A Country-based Surveillance Study.
- Al-Ibraheem A, Abdlkadir AS, Albalooshi B, Alkuwari M, Al Mahariq D, Al-Nabhani K, Alqarni A, Al-Rowaily M, AlSalloum R, Bozkurt MF, Dadgar H, Esmail A, Fatima S, Haidar M, Khalaf A, Mohammed F, Novruzov F, Zein M.
- Nucl Med Mol Imaging. 2025 Mar 20;59(5):351-359. doi: 10.1007/s13139-025-00914-4.
- PMCID: PMC12446171
Al-Ibraheem A, et al.Nucl Med Mol Imaging. 2025.PMCID: PMC12446171 -
Exploring the Diagnostic and Theranostic Role of FAPI PET in Soft Tissue Sarcoma: A Systematic Review.
- Abdulrahman M, Giesel F, Scott AM, Shi H, Zaidi H, Abdlkadir AS, Yaser S, Abuhijlih R, Al-Ibraheem A.
- Nucl Med Mol Imaging. 2025 Aug 16;59(5):289-305. doi: 10.1007/s13139-025-00936-y.
- PMCID: PMC12446160
Abdulrahman M, et al.Nucl Med Mol Imaging. 2025.PMCID: PMC12446160 -
Real Challenges Before, During, and after Establishing a Theranostics Center in Developing Countries.
- Bautista-Peñalosa P.
- Nucl Med Mol Imaging. 2025 Apr 15;59(5):371-375. doi: 10.1007/s13139-025-00918-0.
- PMCID: PMC12446168
Bautista-Peñalosa P.Nucl Med Mol Imaging. 2025.PMCID: PMC12446168